Daniyal Hussain leads Technology Business Development at GSK, where he oversees partnerships spanning data, AI, and platform technologies to accelerate drug discovery and development. He previously held senior roles at Valo Health, where he built data partnerships and in-licensed platform technologies, and at AstraZeneca, where he worked on immuno-oncology strategy. Daniyal began his career in life science consulting, advising on corporate development and valuation. He holds an MBA and MPH from Columbia University and dual bachelor’s degrees from the University of Pennsylvania.